5-LO (St Charles Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-LO (St Charles Pharmaceuticals)
Drug Alias Name5-lipoxygenase inhibitors (St Charles Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 5-lipoxygenase
Therapy Area/IndicationsCentral Nervous System Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLouisiana State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLouisiana State UniversitySt Charles Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsCentral Nervous System Infections

Other Information

ATC CodeN/A
Related LinksN/A